Metraipolis › archive › dc_bd5c85732d98

Reevaluating the senolytic activity of a GLS1 inhibitor and an anti-PD-1 antibody: toward greater reproducibility and methodological rigor — Europe PMC PMID:41933117

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41933117
DOI
10.1038/s44319-[numero omesso]-5
License (as archived)
solo-consultazione
Archived
2026-11-03T09:33:00.340Z
SHA-256 of the archived text
ead1032a9de8483a9ca422153a725e848b49f0ccb512cc074a350fe33402b22b
Stable URL of this page
https://metraipolis.com/documento/dc_bd5c85732d98

How to cite

Reevaluating the senolytic activity of a GLS1 inhibitor and an anti-PD-1 antibody: toward greater reproducibility and methodological rigor — Europe PMC PMID:41933117 — Europe PMC (en), https://europepmc.org/article/MED/41933117 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_bd5c85732d98 (Metraipolis archive dc_bd5c85732d98, sha256 ead1032a9de8483a9ca422153a725e848b49f0ccb512cc074a350fe33402b22b)
BibTeX
@misc{dcbd5c85732d98,
  title = {Reevaluating the senolytic activity of a GLS1 inhibitor and an anti-PD-1 antibody: toward greater reproducibility and methodological rigor — Europe PMC PMID:41933117},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41933117},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_bd5c85732d98; sha256 ead1032a9de8483a9ca422153a725e848b49f0ccb512cc074a350fe33402b22b},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41933117. Agents can read the archived copy with the MCP tool read_document.